[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100527082":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":25,"responsibleParty":68,"collaborators":70,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":78,"acronym":79,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":10,"studyType":87,"phases":10,"briefSummary":88,"conditions":89,"keywords":10,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"Artcline GmbH","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Control group",null,"Subjects in this group where randomized in the control group in the ReActiF-ICE study previously",{"label":13,"type":10,"description":14,"interventionNames":10},"Therapy Group","Subjects in this group where randomized in the therapy group in the ReActiF-ICE study previously",[16,21],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Erdmann J Zippel, RN","CONTACT","+4915772371146","erdmann.zippel@artcline.de",{"name":22,"role":18,"phone":23,"phoneExt":10,"email":24},"Jens Altrichter, MD","+49 3814407030","jens.altrichter@artcline.de",[26,49],{"facility":27,"status":28,"city":29,"state":10,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Klinikum Magdeburg, Klinik für Intensiv- und Rettungsmedizin","RECRUITING","Magdeburg","39130","Germany","DE",{"type":34,"coordinates":35},"Point",[36,37],11.63189,52.13129,{"lat":37,"lon":36},[40,45],{"name":41,"role":18,"phone":42,"phoneExt":43,"email":44},"Martin Sauer, Pof. Dr.","+49391791","3105","martin.sauer@klinikum-magdeburg.de",{"name":46,"role":18,"phone":42,"phoneExt":47,"email":48},"Brigitte Specht, RN","7839","brigitte.specht@klinikum-magdeburg.de",{"facility":50,"status":28,"city":51,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Universitätsmedizin Rostock, Abteilung KAI","Rostock",{"type":34,"coordinates":53},[54,55],12.14049,54.0887,{"lat":55,"lon":54},[58,63],{"name":59,"role":18,"phone":60,"phoneExt":61,"email":62},"Daniel Reuter, Prof. Dr.","+49381-494","6401","Daniel.Reuter@med.uni-rostock.de",{"name":64,"role":18,"phone":65,"phoneExt":66,"email":67},"Heike Lösecke, RN","+49381494","146447","Heike.Loesecke@med.uni-rostock.de",{"type":69,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[71],{"name":72,"class":73},"ZKS Jena","UNKNOWN","100527082","recovery-from-acute-immune-failure-in-septic-shock-by-immune-cell-extracorporeal-therapy---observational-long-term-outcome-follow-up-100527082",false,"NCT06143137","Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy - Observational Long-term Outcome Follow up","ReActIF- LTO","Inclusion Criteria:\n\n1. Subject or legal surrogate is willing and able to provide written informed consent and comply with all protocol requirements or the implementation of other established procedures according to the local regulations of the contributing center to include subjects who are unable to provide informed consent.\n2. Subject was enrolled in the ReActIF-ICE study and successfully passed the Day 2 re-evaluation of that trial.\n\nExclusion Criteria:\n\n* none","ALL","18 Years","80 Years",{"count":85,"type":86},142,"ESTIMATED","OBSERVATIONAL","Subjects previously enrolled \u002F randomized in the ReActIF-ICE (Recovery from acute immune failure in septic shock by immune cell extracorporeal terapy - immune competence enhancement) study received either standard sepsis treatment (control group) or standard sepsis treatment and additionally the ARTICE treatment (treatment group) during their index hospitalization. All subjects are followed up for 90 days after enrollment.\n\nIn this long term follow up study, the enrolled subjects shall be followed up beyond 90 days for up to 5 years.",[90],"Severe Sepsis","2024-08-01",{"date":93,"type":94},"2024-08-02","ACTUAL",{"date":96,"type":94},"2024-01-01",{"date":98,"type":86},"2030-02-28",{"name":5,"class":6},2]